SCHEMBL26995652

SCHEMBL26995652

CN(CCc1cccc(OCCN2CCC(F)(F)CC2)c1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
KCNH2 Q12809 1/20 0.40
EPHX2 P34913 1/20 0.40
SIGMAR1 Q99720 2/20 0.39
CYP2D6 P10635 2/20 0.39
LTB4R Q15722 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831657 1.00 PDK2 (0.43) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL30831453 0.95 PDK2 (0.42) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL26995637 0.95 PDK2 (0.42) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL26985807 0.89 KDM4E (0.55) KDM4EALDH1A1SMN1; SMN2GAAHTT
SCHEMBL26985729 0.88 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL26985730 0.87 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HTTEPHX2
SCHEMBL26985802 0.85 PDK2 (0.40) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL31506023 0.84 BCHE (0.43) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL31506013 0.84 BCHE (0.43) PDK2KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL31755841 0.84 BCHE (0.43) PDK2KDM4EALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed